| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.16B | +21.7% |
| Gross profit | ¥0.06B | — |
| Operating income | ¥-0.00B | — |
| Net income | ¥-0.00B | -114.6% |
| Gross margin | 35.0% | Net margin -2.2% |
| Revenue Q/Q | -40.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.11B | 65.0% |
| R&D | ¥0.02B | 11.7% |
| SG&A | ¥0.04B | 22.2% |
| Tax & other | ¥0.00B | 0.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
浙江恒威 ・ 中荣股份 ・ 恒勃股份 ・ 祥明智能 ・ 森鹰窗业 ・ 实朴检测 ・ 纽泰格 ・ 泓博医药 ・ 荣信文化 ・ 飞沃科技 ・ 盛帮股份 ・ 五洲医疗
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies